Condition
Awake Endotracheal Intubation
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown1
Not Yet Recruiting1
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07484841Not ApplicableNot Yet Recruiting
Comparison of Awake Tracheal Intubation Methods
NCT06026566Not ApplicableUnknown
Compatible Effect of Remimazolam Besylate Combined With Afentanil for ATI
NCT01848548TerminatedPrimary
Superior Laryngeal Nerve Block For Awake Endotracheal Intubation Study
Showing all 3 trials